tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

IDT Australia Limited Announces Cessation of Securities

Story Highlights
  • IDT Australia Limited operates in the pharmaceutical industry, focusing on drug formulation and production.
  • The company announced the cessation of 2,155,000 securities due to unmet conditions, impacting its capital structure.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
IDT Australia Limited Announces Cessation of Securities

Meet Your ETF AI Analyst

IDT Australia Limited ( (AU:IDT) ) has issued an announcement.

IDT Australia Limited announced the cessation of 2,155,000 ordinary fully paid securities due to the lapse of conditional rights, as the conditions were not met or became incapable of being satisfied. This cessation may impact the company’s capital structure and could have implications for its market positioning and stakeholder interests.

More about IDT Australia Limited

IDT Australia Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company is known for its expertise in drug formulation and production, serving various market segments within the healthcare sector.

Average Trading Volume: 327,947

Technical Sentiment Signal: Sell

Current Market Cap: A$24.81M

Find detailed analytics on IDT stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1